While the tumor marker carbohydrate antigen 19-9 (CA19-9) and carcinoembryonic antigen (CEA) often correlate with therapeutic response and tumor recurrence, they have neither sensitivity nor specificity [4]. The gene discussed is CEACAM5; the disease is neoplasm.